TMS Treatment is the Focus of a New "Leading Edge" Segment with Host Jimmy Johnson

New Segment Helps to Educate on New Treatment Options for Patients

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

(PRWEB) February 13, 2014

Transcranial Magnetic Stimulation, or TMS, is a new FDA approved treatment for neurological and psychiatric conditions. It is particularly being used to treat Parkinson's Disease, strokes, migraine headaches, severe depression and dystonia. Depending on the severity of the condition, the treatment may be repeated several times before the healing process begins.

The way TMS treatment works is through weak electrical currents or a magnet that causes slight discomfort in the brain. Due to the current, the brain cells in the area are stimulated. Depending on the condition and the goal of treatment, the process may stop certain impulses or messages from being sent throughout the body or it may help send messages. The weak electrical or magnetic pulse can interrupt certain signals from the brain, which helps prevent the physical condition or improves the brain's ability to send certain messages.

Jimmy Johnson will host a new "Leading Edge" segment on TMS treatments. During the program, you will learn how the treatment works, the impact it has on the brain and the potential downsides of using the treatment. The segment will explain the benefits, risks and potential side effects of the treatment so that you can understand the latest innovations in medicine.

"Leading Edge" is a public broadcast that is not distributed by PBS. Visit the website at http://www.leadingedgeseries.com to learn more about the TMS treatment segments or any other upcoming segments that will be available.


Contact